You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperoxaluria, Primary

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mortality of Rare Diseases in Taiwan With Real-world Evidence

Completed
  • Rare Diseases
  • +5 more
  • longitudinal observational study
  • Tainan, Taiwan
    Department of Family Medicine, National Cheng Kung Univ Hosp
May 9, 2022

Proteomics of Primary Hyperoxaluria Type 1

Completed
  • Primary Hyperoxaluria Type 1
  • Observational
  • (no location specified)
Jun 10, 2019

Secondary Hyperoxaluria, Nephrolithiasis, Hyperoxaluria Trial in United States (Test Meal)

Completed
Has Results
  • Secondary Hyperoxaluria
  • +3 more
  • Test Meal
  • Tucson, Arizona
  • +4 more
Oct 5, 2021

Primary Hyperoxaluria Type 1 Trial in Bonn, Amsterdam (DCR-PH1, Placebo)

Terminated
  • Primary Hyperoxaluria Type 1
  • Bonn, Germany
  • +1 more
Oct 1, 2018

Renal Calculi Trial in Mansoura (percutaneous nephrlolithotomy, VDR gene, CASR gene)

Recruiting
  • Renal Calculi
  • percutaneous nephrlolithotomy
  • VDR gene, CASR gene
  • Mansoura, Outside U.S./Canada, Egypt
    Mansoura University
Jul 25, 2023

Hypercalciuria, Urolithiasis Trial (Radiological testing, Pediatric Urologic DNA and History Repository)

Available
  • Hypercalciuria
  • Urolithiasis
  • Radiological testing
  • Pediatric Urologic DNA and History Repository
  • (no location specified)
Aug 31, 2022

Kidney Calculi, Crohn's Disease Trial in Vancouver (Calcium Carbonate)

Recruiting
  • Kidney Calculi
  • Crohn's Disease
  • Calcium Carbonate
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
May 16, 2022

Urolithiasis, Hyperoxaluria Trial in Vienna (Dapagliflozin, Hydrochlorothiazide)

Not yet recruiting
  • Urolithiasis
  • Hyperoxaluria
  • Vienna, Austria
    Medical University of Vienna
Jun 29, 2022

Healthy, Enteric Hyperoxaluria Trial in Cincinnati (FB-001, Placebo)

Recruiting
  • Healthy
  • Enteric Hyperoxaluria
  • FB-001
  • Placebo
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Jan 23, 2023

Monogenic Kidney Stone - Genetic Testing

Recruiting
  • Rare Kidney Stone Diseases
    • Rochester, Minnesota
      Mayo Clinic
    Sep 2, 2021

    Enteric Hyperoxaluria Trial in New York (Moderately High Oxalate (MOx) Diet)

    Recruiting
    • Enteric Hyperoxaluria
    • Moderately High Oxalate (MOx) Diet
    • New York, New York
      NYU Langone Health
    Nov 10, 2022

    Urolithiasis, Hyperoxaluria Trial in Karachi (Oxalate to creatinine ratio)

    Completed
    • Urolithiasis
    • Hyperoxaluria
    • Oxalate to creatinine ratio
    • Karachi, Pakistan, Sindh, Pakistan
      Syed bilal hashmi
    Sep 30, 2020

    Bariatric Surgery Candidate, Kidney Stone Trial in Chicago (Special low-oxalate diet followed by all-day visit to University of

    Not yet recruiting
    • Bariatric Surgery Candidate
    • Kidney Stone
    • Special low-oxalate diet followed by all-day visit to University of Chicago research clinic
    • Chicago, Illinois
      University of Chicago Medical Center
    Apr 26, 2022

    Healthy Volunteers, Enteric Hyperoxaluria Trial in Canada, United States (combination product, biological, drug)

    Recruiting
    • Healthy Volunteers
    • Enteric Hyperoxaluria
    • NOV-001
    • +3 more
    • Birmingham, Alabama
    • +14 more
    Jun 24, 2022

    Healthy Trial in Birmingham (Low oxalate controlled Diet, Primed, continuous intravenous infusion of 13C2-Glycolate, Bolus

    Recruiting
    • Healthy
    • Low oxalate controlled Diet
    • +3 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 5, 2021

    Reference Interval of Spot Urinary Oxalate to Creatinine Ratio

    Completed
    • Hyperoxaluria
      • Karachi, Sindh, Pakistan
        Syed bilal hashmi
      Feb 15, 2021

      Sepsis Trial in Kigali (Ascorbic Acid 500Mg/Ml Inj, Dextrose in Water)

      Withdrawn
      • Sepsis
      • Ascorbic Acid 500Mg/Ml Inj
      • Dextrose in Water
      • Kigali, Rwanda
        University Teaching Hospital of Kigali
      Oct 14, 2022

      Secondary Hyperoxaluria, Nephrolithiasis Trial in Brussels (Lanthanum Carbonate)

      Recruiting
      • Secondary Hyperoxaluria
      • Nephrolithiasis
      • Lanthanum Carbonate
      • Brussels, Belgium
        University Hospital Brussels
      Jan 7, 2021

      Healthy, Enteric Hyperoxaluria Trial in United States (SYNB8802, Placebo)

      Recruiting
      • Healthy
      • Enteric Hyperoxaluria
      • Tucson, Arizona
      • +3 more
      May 11, 2021

      Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

      Recruiting
      • Unknown Primary Tumors
      • Oropharynx Cancer
      • Detection of lesions using fluorescence molecular imaging
      • Groningen, Netherlands
        University Medical Center Groningen
      Oct 20, 2023

      Behavioral Economics, Primary Health Care, Health Maintenance Trial in Los Angeles (Standard Communication Email, Personalized

      Recruiting
      • Behavioral Economics
      • +2 more
      • Standard Communication Email
      • +2 more
      • Los Angeles, California
        UCLA Health Department of Medicine, Quality Office
      Dec 1, 2023

      Gut Microbiome Alterations in Hyperoxaluric Patients

      Unknown status
      • Oxalate, Primary Hyperoxaluria, Microbiome
        • New York, New York
          New York University School of Medicine
        Sep 23, 2017

        Caries of Infancy Trial in Ismailia (stainless steel crown, zirconia crown, fiberglass crown)

        Completed
        • Caries of Infancy
        • stainless steel crown
        • +2 more
        • Ismailia, Egypt
          faculty of dentistry Suez canal university
        Aug 19, 2023

        Role of PET/CT in Peritoneal Deposits Assessment

        Not yet recruiting
        • Peritoneal Metastases
        • PET/CT
        • (no location specified)
        Nov 14, 2023

        Primary IgA Nephropathy Trial (HRS-5965, Placebo)

        Not yet recruiting
        • Primary IgA Nephropathy
        • (no location specified)
        Nov 14, 2023